By CHAD BRAY
A unit of the Swiss drug maker would acquire Seragon, a privately held biotechnology firm based in San Diego that was spun off from Aragon Pharmaceuticals last year.
Published: July 2, 2014 at 4:00AM
from NYT Business Day http://ift.tt/1qPJNKG
from WordPress http://ift.tt/1mIMLLC
via Hadi Aboukhater
No comments:
Post a Comment